ACR 2022 Archives - Medical Conferences

Home > Rheumatology > ACR 2022

Read the full Report (pdf)

American College of Rheumatology 10–14 November 2022 Philadelphia, USA

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

Presented By

Prof. Thomas Dörner, Charité University Hospital, Germany

Trial

Phase 2, LOUiSSE

Conference

ACR 2022

Type

News article

1 December 2022 13:19

Early treatment: a key to improved outcomes in polyarticular JIA

Presented By

Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA

Trial

STOP-JIA

Conference

ACR 2022

Type

News article

1 December 2022 12:23

Online First

ACR 2022 Congress Round-Up

Glucocorticoids in rheumatic diseases: Is there a skeletal sparing dose?

Presented By

Dr Giovanni Adami, University of Verona, Italy

Conference

ACR 2022

Type

News article

1 December 2022 14:37

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Presented By

Prof. Christopher Ritchlin, University of Rochester Medical Center, USA

Trial

Phase 3

Conference

ACR 2022

Type

News article

1 December 2022 14:33

Stimulation of PD-1: a new concept to treat RA

Presented By

Prof. Paul Emery, University of Leeds, UK

Trial

Phase 2

Conference

ACR 2022

Type

News article

1 December 2022 14:28

Denosumab in erosive hand arthritis: Structure repair of interphalangeal joints seems possible

Presented By

Prof. Ruth Wittoek, Ghent University Hospital, Belgium

Trial

Phase 2

Conference

ACR 2022

Type

News article

1 December 2022 14:25

High retention rates after switching between infliximab biosimilars

Presented By

Dr Hafsah Nabi, Rigshospitalet, Denmar

Conference

ACR 2022

Type

News article

1 December 2022 14:21

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Presented By

Dr Sinead Magui, St. James’ Hospital, Ireland

Conference

ACR 2022

Type

News article

1 December 2022 14:12

Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression

Presented By

Dr Fabian Proft, Charité University Hospital, Germany

Trial

Phase 4, CONSUL

Conference

ACR 2022

Type

News article

1 December 2022 14:08

Diet and exercise programme: a successful OA strategy in a community-based setting

Presented By

Prof. Stephen Messier, Wake Forest University, USA

Conference

ACR 2022

Type

News article

1 December 2022 13:23

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

Presented By

Prof. Thomas Dörner, Charité University Hospital, Germany

Trial

Phase 2, LOUiSSE

Conference

ACR 2022

Type

News article

1 December 2022 13:19

A novel risk score helps identify interstitial lung disease in patients with systemic sclerosis

Presented By

Dr Cosimo Bruni, University of Zürich, Switzerla

Conference

ACR 2022

Type

News article

1 December 2022 12:27

Early treatment: a key to improved outcomes in polyarticular JIA

Presented By

Prof. Yukiko Kimura, Hackensack Meridian School of Medicine, USA

Trial

STOP-JIA

Conference

ACR 2022

Type

News article

1 December 2022 12:23

TYK2 inhibition shows potential as a treatment for SLE

Presented By

Dr Marilyn Pike, MedPharm Consulting, MA, USA

Trial

Phase 2, PAISLEY

Conference

ACR 2022

Type

News article

1 December 2022 12:19

Belimumab efficacious in cutaneous lupus erythematosus

Presented By

Dr Daniel Montes, University of Wisconsin, WI, USA

Conference

ACR 2022

Type

News article

1 December 2022 12:09

No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies

Presented By

Dr Juan Molina Collada , Gregorio Marañón General University Hospital, Spain

Trial

BIOBADASER

Conference

ACR 2022

Type

News article

1 December 2022 12:03

Medical Conferences

ACR 2022

Featured articles

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

Early treatment: a key to improved outcomes in polyarticular JIA

CONTENTS

Online First

ACR 2022 Congress Round-Up

Glucocorticoids in rheumatic diseases: Is there a skeletal sparing dose?

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Stimulation of PD-1: a new concept to treat RA

Denosumab in erosive hand arthritis: Structure repair of interphalangeal joints seems possible

High retention rates after switching between infliximab biosimilars

New analysis assesses the safety of tofacitinib regarding extended MACE

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression

Diet and exercise programme: a successful OA strategy in a community-based setting

Bruton’s tyrosine kinase inhibition: a novel treatment option for Sjögren’s syndrome?

A novel risk score helps identify interstitial lung disease in patients with systemic sclerosis

Early treatment: a key to improved outcomes in polyarticular JIA

TYK2 inhibition shows potential as a treatment for SLE

Belimumab efficacious in cutaneous lupus erythematosus

No increased cancer risk in patients with rheumatic diseases and prior malignancy treated with novel therapies